These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 17460400)

  • 1. Serum levels of the Th1 promoter IL-12 and the Th2 chemokine TARC are elevated in erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis and correlate with soluble Fas ligand expression. An immunoenzymatic study from the Italian Group of Immunopathology.
    Quaglino P; Caproni M; Antiga E; Del Bianco E; Osella-Abate S; Savoia P; Frezzolini A; Schena D; Marzano A; Volpi W; De Simone C; Parodi A; Fabbri P; Bernengo MG;
    Dermatology; 2007; 214(4):296-304. PubMed ID: 17460400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Caproni M; Torchia D; Schincaglia E; Volpi W; Frezzolini A; Schena D; Marzano A; Quaglino P; De Simone C; Parodi A; Barletta E; Fabbri P
    Br J Dermatol; 2006 Oct; 155(4):722-8. PubMed ID: 16965421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
    Caproni M; Torchia D; Schincaglia E; Volpi W; Frezzolini A; Schena D; Marzano A; Quaglino P; De Simone C; Parodi A; Barletta E; Fabbri P
    Br J Dermatol; 2006 Feb; 154(2):319-24. PubMed ID: 16433803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased soluble Fas ligand levels in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis preceding skin detachment.
    Murata J; Abe R; Shimizu H
    J Allergy Clin Immunol; 2008 Nov; 122(5):992-1000. PubMed ID: 18692887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis.
    Shimada Y; Takehara K; Sato S
    J Dermatol Sci; 2004 May; 34(3):201-8. PubMed ID: 15113590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both Th1 and Th2 chemokines are elevated in sera of patients with autoimmune blistering diseases.
    Echigo T; Hasegawa M; Shimada Y; Inaoki M; Takehara K; Sato S
    Arch Dermatol Res; 2006 Jun; 298(1):38-45. PubMed ID: 16583210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand.
    Abe R; Shimizu T; Shibaki A; Nakamura H; Watanabe H; Shimizu H
    Am J Pathol; 2003 May; 162(5):1515-20. PubMed ID: 12707034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of a Th1 chemoattractant IP-10 and Th2 chemoattractants, TARC and MDC, are elevated in patients with systemic sclerosis.
    Fujii H; Shimada Y; Hasegawa M; Takehara K; Sato S
    J Dermatol Sci; 2004 Jun; 35(1):43-51. PubMed ID: 15194146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cultured human endometrial epithelial cells produce thymus and activation-regulated chemokine with stimulation of interleukin-4 and interleukin-13.
    Nasu K; Sun B; Nishida M; Fukuda J; Narahara H; Miyakawa I
    Fertil Steril; 2004 Oct; 82 Suppl 3():1014-8. PubMed ID: 15474066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for TARC/CCL17, a CC chemokine, in systemic lupus erythematosus.
    Okamoto H; Koizumi K; Yamanaka H; Saito T; Kamatani N
    J Rheumatol; 2003 Nov; 30(11):2369-73. PubMed ID: 14677179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxic epidermal necrolysis and Stevens-Johnson syndrome: soluble Fas ligand involvement in the pathomechanisms of these diseases.
    Abe R
    J Dermatol Sci; 2008 Dec; 52(3):151-9. PubMed ID: 18657400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monocyte-derived dendritic cells exposed to Der p 1 allergen enhance the recruitment of Th2 cells: major involvement of the chemokines TARC/CCL17 and MDC/CCL22.
    Hammad H; Smits HH; Ratajczak C; Nithiananthan A; Wierenga EA; Stewart GA; Jacquet A; Tonnel AB; Pestel J
    Eur Cytokine Netw; 2003; 14(4):219-28. PubMed ID: 14715413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of thymus and activation-regulated chemokine (TARC/CCL17) as a potential marker for early indication of disease and prediction of disease activity in drug-induced hypersensitivity syndrome (DIHS)/drug rash with eosinophilia and systemic symptoms (DRESS).
    Ogawa K; Morito H; Hasegawa A; Daikoku N; Miyagawa F; Okazaki A; Fukumoto T; Kobayashi N; Kasai T; Watanabe H; Sueki H; Iijima M; Tohyama M; Hashimoto K; Asada H
    J Dermatol Sci; 2013 Jan; 69(1):38-43. PubMed ID: 23141052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokine expression in diverse nonimmediate drug hypersensitivity reactions: focus on thymus activation-regulated chemokine, cutaneous T-cell-attracting chemokine, and interleukin-10.
    Wang F; He D; Tang X; Zhang X
    Ann Allergy Asthma Immunol; 2014 Aug; 113(2):204-8. PubMed ID: 24932689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of both CCR4-active and CXCR3-active chemokines during human allergic pulmonary late-phase reactions.
    Bochner BS; Hudson SA; Xiao HQ; Liu MC
    J Allergy Clin Immunol; 2003 Nov; 112(5):930-4. PubMed ID: 14610482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.
    Chang YS; Huang FC; Tseng SH; Hsu CK; Ho CL; Sheu HM
    Cornea; 2007 Feb; 26(2):123-9. PubMed ID: 17251797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of thymus and activation-regulated chemokine and macrophage-derived chemokine by CCR4+ adult T-cell leukemia cells.
    Shimauchi T; Imai S; Hino R; Tokura Y
    Clin Cancer Res; 2005 Mar; 11(6):2427-35. PubMed ID: 15788694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with IFN-gamma increases serum levels of Th1 chemokines and decreases those of Th2 chemokines in patients with mycosis fungoides.
    Hino R; Shimauchi T; Tokura Y
    J Dermatol Sci; 2005 Jun; 38(3):189-95. PubMed ID: 15927812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinguishing between erythema multiforme major and Stevens-Johnson syndrome/toxic epidermal necrolysis immunopathologically.
    Iwai S; Sueki H; Watanabe H; Sasaki Y; Suzuki T; Iijima M
    J Dermatol; 2012 Sep; 39(9):781-6. PubMed ID: 22458564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating levels of both Th1 and Th2 chemokines are elevated in patients with sarcoidosis.
    Nureki S; Miyazaki E; Ando M; Ueno T; Fukami T; Kumamoto T; Sugisaki K; Tsuda T
    Respir Med; 2008 Feb; 102(2):239-47. PubMed ID: 17949965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.